232 related articles for article (PubMed ID: 28891012)
1. Visualization of multiple organ amyloid involvement in systemic amyloidosis using
Ezawa N; Katoh N; Oguchi K; Yoshinaga T; Yazaki M; Sekijima Y
Eur J Nucl Med Mol Imaging; 2018 Mar; 45(3):452-461. PubMed ID: 28891012
[TBL] [Abstract][Full Text] [Related]
2. In vivo visualization of amyloid deposits in the heart with 11C-PIB and PET.
Antoni G; Lubberink M; Estrada S; Axelsson J; Carlson K; Lindsjö L; Kero T; Långström B; Granstam SO; Rosengren S; Vedin O; Wassberg C; Wikström G; Westermark P; Sörensen J
J Nucl Med; 2013 Feb; 54(2):213-20. PubMed ID: 23238792
[TBL] [Abstract][Full Text] [Related]
3. Positron emission tomography (PET) utilizing Pittsburgh compound B (PIB) for detection of amyloid heart deposits in hereditary transthyretin amyloidosis (ATTR).
Pilebro B; Arvidsson S; Lindqvist P; Sundström T; Westermark P; Antoni G; Suhr O; Sörensen J
J Nucl Cardiol; 2018 Feb; 25(1):240-248. PubMed ID: 27645889
[TBL] [Abstract][Full Text] [Related]
4. Early Detection of Multiorgan Light-Chain Amyloidosis by Whole-Body
Ehman EC; El-Sady MS; Kijewski MF; Khor YM; Jacob S; Ruberg FL; Sanchorawala V; Landau H; Yee AJ; Bianchi G; Di Carli MF; Falk RH; Hyun H; Dorbala S
J Nucl Med; 2019 Sep; 60(9):1234-1239. PubMed ID: 30954943
[TBL] [Abstract][Full Text] [Related]
5. Accurate analysis and visualization of cardiac (11)C-PIB uptake in amyloidosis with semiautomatic software.
Kero T; Lindsjö L; Sörensen J; Lubberink M
J Nucl Cardiol; 2016 Aug; 23(4):741-50. PubMed ID: 26173894
[TBL] [Abstract][Full Text] [Related]
6. 11C-Pittsburgh B PET imaging in cardiac amyloidosis.
Lee SP; Lee ES; Choi H; Im HJ; Koh Y; Lee MH; Kwon JH; Paeng JC; Kim HK; Cheon GJ; Kim YJ; Kim I; Yoon SS; Seo JW; Sohn DW
JACC Cardiovasc Imaging; 2015 Jan; 8(1):50-59. PubMed ID: 25499132
[TBL] [Abstract][Full Text] [Related]
7. Extracardiac
Wagner T; Page J; Burniston M; Skillen A; Ross JC; Manwani R; McCool D; Hawkins PN; Wechalekar AD
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(7):1129-1138. PubMed ID: 29651545
[TBL] [Abstract][Full Text] [Related]
8. Amyloid PET imaging in cardiac amyloidosis: a pilot study using
Dietemann S; Nkoulou R
Ann Nucl Med; 2019 Aug; 33(8):624-628. PubMed ID: 31140154
[TBL] [Abstract][Full Text] [Related]
9. Quantification of β-Amyloidosis and rCBF with Dedicated PET, 7 T MR Imaging, and High-Resolution Microscopic MR Imaging at 16.4 T in APP23 Mice.
Maier FC; Keller MD; Bukala D; Bender B; Mannheim JG; Brereton IM; Galloway GJ; Pichler BJ
J Nucl Med; 2015 Oct; 56(10):1593-9. PubMed ID: 26251417
[TBL] [Abstract][Full Text] [Related]
10. Cerebral amyloid angiopathy in posttransplant patients with hereditary ATTR amyloidosis.
Sekijima Y; Yazaki M; Oguchi K; Ezawa N; Yoshinaga T; Yamada M; Yahikozawa H; Watanabe M; Kametani F; Ikeda S
Neurology; 2016 Aug; 87(8):773-81. PubMed ID: 27466465
[TBL] [Abstract][Full Text] [Related]
11. Biodistribution and radiation dosimetry of the amyloid imaging agent 11C-PIB in humans.
Scheinin NM; Tolvanen TK; Wilson IA; Arponen EM; Någren KA; Rinne JO
J Nucl Med; 2007 Jan; 48(1):128-33. PubMed ID: 17204709
[TBL] [Abstract][Full Text] [Related]
12. Comparison of [
Lowe VJ; Lundt E; Knopman D; Senjem ML; Gunter JL; Schwarz CG; Kemp BJ; Jack CR; Petersen RC
Neuroimage Clin; 2017; 16():295-302. PubMed ID: 28856092
[TBL] [Abstract][Full Text] [Related]
13. Amyloid imaging mismatch.
Minamimoto R; Ishii K; Kubota K; Morooka M; Okasaki M; Ito K; Mitsumoto T; Nakajima K; Sato T; Mochizuki M; Okazaki O
Clin Nucl Med; 2012 Aug; 37(8):807-9. PubMed ID: 22785519
[TBL] [Abstract][Full Text] [Related]
14.
Higashi T; Nishii R; Kagawa S; Kishibe Y; Takahashi M; Okina T; Suzuki N; Hasegawa H; Nagahama Y; Ishizu K; Oishi N; Kimura H; Watanabe H; Ono M; Saji H; Yamauchi H
Ann Nucl Med; 2018 Apr; 32(3):206-216. PubMed ID: 29388083
[TBL] [Abstract][Full Text] [Related]
15. Quantification of
Kero T; Sörensen J; Antoni G; Wilking H; Carlson K; Vedin O; Rosengren S; Wikström G; Lubberink M
J Nucl Cardiol; 2020 Jun; 27(3):774-784. PubMed ID: 30039218
[TBL] [Abstract][Full Text] [Related]
16. 11C-PiB PET/CT in nasopharyngeal amyloidosis associated with multiple myeloma.
Ishimura M; Yamamoto Y; Kimura N; Hoshikawa H; Nishiyama Y
Clin Nucl Med; 2015 Feb; 40(2):e161-2. PubMed ID: 25140565
[TBL] [Abstract][Full Text] [Related]
17. Amyloid imaging with (11)C-PIB PET/CT and glucose metabolism with (18)F-FDG PET/CT in a study on cognitive impairment in the clinical setting.
Banzo I; Jiménez-Bonilla J; Ortega-Nava F; Quirce R; Martínez-Rodríguez I; de Arcocha-Torres M; Rodríguez E; Vázquez JL; Sánchez PJ; Martínez-Amador N; Ibañez-Bravo S; Carril JM
Nucl Med Commun; 2014 Mar; 35(3):238-44. PubMed ID: 24240196
[TBL] [Abstract][Full Text] [Related]
18. Significance of
Minamimoto R; Awaya T; Iwama K; Hotta M; Nakajima K; Hirai R; Okazaki O; Hiroi Y
J Nucl Cardiol; 2020 Feb; 27(1):202-209. PubMed ID: 29589208
[TBL] [Abstract][Full Text] [Related]
19. The flutemetamol analogue cyano-flutemetamol detects myocardial AL and ATTR amyloid deposits: a post-mortem histofluorescence analysis.
Abrahamson EE; Padera RF; Davies J; Farrar G; Villemagne VL; Dorbala S; Ikonomovic MD
Amyloid; 2023 Jun; 30(2):169-187. PubMed ID: 36411500
[TBL] [Abstract][Full Text] [Related]
20. Atrophy rates in asymptomatic amyloidosis: implications for Alzheimer prevention trials.
Andrews KA; Modat M; Macdonald KE; Yeatman T; Cardoso MJ; Leung KK; Barnes J; Villemagne VL; Rowe CC; Fox NC; Ourselin S; Schott JM;
PLoS One; 2013; 8(3):e58816. PubMed ID: 23554933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
